Moderna says its Covid-19 shot remains 93% effective 4-6 months after second dose


NEW YORK (Reuters): Moderna Inc said on Thursday (Aug 5) its Covid-19 shot was about 93% effective four to six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.

That compares favourably to data released by rivals Pfizer Inc and BioNTech SE last week in which they suggested their vaccine's efficacy waned around 6% every two months, declining to around 84% six months after the second shot. Both the Moderna and Pfizer-BioNTech vaccines are based on messenger RNA (mRNA) technology.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

South Korea fines Meta about $15 million over collection of user data
Thai pygmy hippo Moo Deng makes bold US election prediction
Johor first in country to offer starting salaries of RM4,000 to RM5,000, says TMJ
MACC officer charged with misappropriating RM613,000 property
Chinese man has one wife, four lovers, all living in same complex, unaware of each other
FashionValet founders arrive at MACC HQ to record statement
Prosecution seeking heavier sentence for celebrity preacher convicted of rape
Indonesia and Cambodia look to strengthen united front against trafficking
Taiwan couple charged with trying to influence elections for China
More than 10,000 North Korean troops in Russia for Ukraine war: South Korea

Others Also Read